For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20171221:nGNE6XydVf
Issue of Second Supplementary Prospectus
The board announces that it has published a second supplementary prospectus
(Second Supplementary Prospectus) relating to the issue of up to 55 million
shares in connection with the merger with Foresight 3 VCT plc through an
acquisition of all of its assets and liabilities and the offer for
subscription to raise up to £50 million with an over-allotment facility for a
further £50 million through the issue of shares.
The Second Supplementary Prospectus refers to the proposed changes to the
rules governing Venture Capital Trusts pursuant to the Patient Capital Review.
Copies of the Second Supplementary Prospectus have been submitted to the
Financial Conduct Authority and will shortly be available for inspection at
the National Storage Mechanism, which is located at:
www.morningstar.co.uk/uk/nsm
Copies of this Second Supplementary Prospectus together with the prospectus
(published on 19 May 2017 and containing details of the Offer) and a first
supplementary prospectus (published on 10 August 2017 in respect of the
audited report and accounts of the Company) are also available from the
following website:
www.foresightgroup.eu
For further enquiries please contact:
Gary Fraser, Foresight Group: 0203 667 8100
This announcement is distributed by Nasdaq Corporate Solutions on behalf of
Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Foresight 4 VCT PLC via Globenewswire